The prognostic role of miR-31 in colorectal cancer: the results of a meta-analysis of 4720 patients
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Epigenomics
- Publicado em
- 13 dez 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The prognostic role of miR-31 in colorectal cancer: the results of a meta-analysis of 4720 patients
Milad Moloudizargari, Jamal Rahmani, Mohammad Hossein Asghari, Ajay Goel
Descritores MeSH
- MicroRNAs
- Antineoplastic Agents
- Colorectal Neoplasms
- Mutation
- Prognosis
- Biomarkers, Tumor
- Proto-Oncogene Proteins B-raf
- Cetuximab
- ErbB Receptors
- Antibodies, Monoclonal
Veja também
Estudos relacionados
- Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
- Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
- Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database